Personalized medicine vs regulation

This op-ed by James A. Bianco, president and CEO of Cell Therapeutics, makes a lot of sense. He says: “What’s missing from the debate is the public policy encouragement to produce more “smart” medicine.”

I agree. All too often, anti-aging activists simply turn to the idea that the solution is more money. While more money may help, it is innovation that will really win the day.

Please follow and like Sonia Arrison:
Personalized medicine vs regulation